サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1446554

腸骨ステントの市場規模、シェア、動向分析レポート：タイプ別、動脈病変別、最終用途別、地域別、セグメント別予測、2024年～2030年

Iliac Stent Market Size, Share & Trends Analysis Report By Type (Self-expandable Stents, Balloon-expandable Stents), By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesion), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 130 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
腸骨ステントの市場規模、シェア、動向分析レポート：タイプ別、動脈病変別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年02月27日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

腸骨ステント市場の成長と動向：

Grand View Research, Incの最新レポートによると、世界の腸骨ステント市場規模は2030年までに15億3,000万米ドルに達する見込みで、2024年から2030年までのCAGRは5.8%で成長すると予測されています。

同市場は、末梢動脈疾患の有病率の増加、医療技術の進歩の拡大、心血管疾患の効果的な治療オプションとしての低侵襲手技に対する認知度の拡大などの要因により成長が見込まれています。

この業界の成長を牽引しているのは、新製品開発と開存性を高めた整列手技です。例えば、自己拡張型ステントは外腸骨動脈の治療において優れた結果を示しています。さらに、末梢動脈疾患（PAD）の有病率の増加が腸骨ステント市場の成長を促進すると予想されています。2023年10月のInstitute for Health Metrics and Evaluationの記事によると、PADの世界的有病率は1.52%、約1億1,300万人とされています。さらに、2022年のNCBIの論文では、PADの年間発症率は1,000万人近くになると予測されています。

腸骨ステントの主要プレーヤー間の戦略的イニシアチブの増加が成長を促進すると予想されています。例えば、2024年1月、Zylox-Tonbridge Medical Technology Co.Ltd.は、末梢静脈ステントシステムの販売承認をNational Medical Products Administration（NMPA）から取得しました。さらに2023年10月には、Getinge ABが米国で腸骨動脈閉塞性疾患治療用のiCastカバーステントシステムの市販を発表しました。

腸骨ステント市場レポートハイライト

  • ヘルスケア産業における腸骨ステント市場は、2023年に10億3,000万米ドルと推定され、2030年には15億3,000万米ドルに達すると予測されます。
  • 腸骨ステント市場は、2024年から2030年にかけて複合年間成長率5.8%で成長し、2030年には15億3,000万米ドルに達すると予測されます。
  • 2023年には、北米が腸骨ステント市場で最大のシェアを占め、売上高シェアは43.7％でした。米国ではPADに罹患しやすい老年人口が増加しているため、ステント留置術の需要が増加し、予測期間中の市場成長に大きく寄与すると予想されます。
  • ステントのタイプ別では、自己拡張型ステントが2023年に60.4％と最大の売上シェアを占め、これはこれらのステントに関する良好な長期臨床試験結果が医療プロバイダーに信頼感を与えることが期待されているためです。
  • 動脈病変別では、総腸骨動脈病変セグメントが2023年に60.5％の最大売上シェアを占めました。高コレステロールや肥満に罹患する患者の増加により、腸骨ステントの需要が高まることが予想されます。
  • 最終用途別では、2023年に病院セグメントが61.7%と圧倒的な売上シェアを占めています。病院は、患者が画像診断、医学的管理、腸骨ステント留置のような介入処置を含む包括的治療を受ける紹介センターとしての役割を果たしています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 腸骨ステント市場：変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 腸骨ステント市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 腸骨ステント市場：タイプの推定・動向分析

  • 腸骨ステント市場：タイプのダッシュボード
  • 腸骨ステント市場：タイプの変動分析
  • 腸骨ステント市場規模、タイプ別、予測および動向分析、2018年から2030年
  • 自己拡張型ステント
  • バルーン拡張型ステント
  • その他

第5章 腸骨ステント市場：動脈病変の推定・動向分析

  • 腸骨ステント市場：動脈病変のダッシュボード
  • 腸骨ステント市場：動脈病変の変動分析
  • 腸骨ステント市場規模、動脈病変別、予測および動向分析、2018年から2030年
  • 総腸骨動脈病変
  • 石灰化病変
  • 完全閉塞性病変

第6章 腸骨ステント市場：最終用途の推定・動向分析

  • 腸骨ステント市場：最終用途のダッシュボード
  • 腸骨ステント市場：最終用途の変動分析
  • 腸骨ステント市場規模、最終用途別、予測および動向分析、2018年から2030年
  • 病院
  • 外来施設
  • その他

第7章 腸骨ステント市場：地域の推定・動向分析、国別、タイプ別、動脈病変別、最終用途別

  • 地域のダッシュボード
  • 市場規模と予測動向分析、2018年から2030年まで
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
  • ベンダー情勢
    • BD
    • Abbott
    • Boston Scientific Corporation
    • WL Gore & Associates, Inc.
    • Cook
    • Medtronic
    • Vascular
    • Terumo Corporation
    • Getinge AB
    • Biotronik SE &Co KG
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 5 North America Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 8 U.S. Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 11 Canada Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 15 Europe Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Germany Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 18 Germany Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 21 UK Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 23 France Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 24 France Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 27 Italy Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 30 Spain Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 33 Denmark Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Sweden Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 35 Sweden Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 36 Sweden Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 38 Norway Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 39 Norway Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 China Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 45 China Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 46 China Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 48 Japan Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 49 Japan Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 51 India Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 52 India Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 South Korea Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 54 South Korea Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 55 South Korea Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Australia Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 57 Australia Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 58 Australia Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Thailand Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 60 Thailand Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 61 Thailand Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 63 Latin America Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 64 Latin America Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 65 Latin America Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Brazil Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 68 Brazil Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 71 Mexico Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 74 Argentina Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 MEA Iliac Stents market, by country, 2018 - 2030 (USD Million)
  • Table 76 MEA Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 77 MEA Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 78 MEA Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 81 South Africa Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 87 UAE Iliac Stents market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Iliac Stents market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Iliac Stents market, by artery lesions, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Iliac Stents market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Iliac Stents Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and artery lesions segment snapshot
  • Fig. 10 End-use segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Market dynamics
  • Fig. 13 Prevalence of PAD in 2022, by WHO regions
  • Fig. 14 Porter's Five Forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Iliac Stents market: Type outlook and key takeaways
  • Fig. 17 Iliac Stents market: Type movement analysis
  • Fig. 18 Self-expandable stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Balloon expandable stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Iliac Stents market: Artery Lesions outlook and key takeaways
  • Fig. 22 Iliac Stents market: Artery Lesions movement analysis
  • Fig. 23 Common Iliac Artery Lesions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Severe Calcified Lesions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Complete Obstructive Lesions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Iliac Stents market: End-use outlook and key takeaways
  • Fig. 27 Iliac Stents market: End-use movement analysis
  • Fig. 28 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Outpatient Facilities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Iliac Stents market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways (1/2)
  • Fig. 33 Regional marketplace: Key takeaways (2/2)
  • Fig. 34 North America Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 U.S. Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 France Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Sweden Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Norway Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Rest of Europe Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Reimbursement scenario
  • Fig. 60 Japan Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Regulatory framework
  • Fig. 63 Reimbursement scenario
  • Fig. 64 China Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Reimbursement scenario
  • Fig. 67 India Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Australia Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 South Korea Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Thailand Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Malaysia Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Vietnam Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Philippines Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Rest of Asia Pacific Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Brazil regulation details
  • Fig. 84 Reimbursement scenario
  • Fig. 85 Brazil Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina pharmaceuticals registration details
  • Fig. 88 Argentina Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Regulatory framework
  • Fig. 91 Reimbursement scenario
  • Fig. 92 Mexico Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Rest of Latin America Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 MEA Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Africa Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Saudi Arabia Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 UAE Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Kuwait Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Rest of MEA Iliac Stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Company market share analysis, 2023
  • Fig. 106 Strategic Framework
目次
Product Code: GVR-4-68040-206-4

Iliac Stent Market Growth & Trends:

The globall iliac stent market size is expected to reach USD 1.53 billion by 2030, projected to grow at a CAGR of 5.8% from 2024 to 2030, based on a new report by Grand View Research, Inc. The market is expected to grow due to factors such as the increasing prevalence of peripheral artery diseases, growing advancements in medical technology, and expanding awareness about minimally invasive procedures as an effective treatment option for cardiovascular diseases.

The industry's growth is driven by new product development and aligned procedures with enhanced patency. For instance, self-expanding stents have demonstrated exceptional results in the treatment of external iliac artery. Furthermore, the growing prevalence of peripheral artery disease (PAD) is expected to propel iliac stents market growth. According to an article by the Institute for Health Metrics and Evaluation in October 2023, the global prevalence of PAD was pegged at 1.52% or nearly 113 million people. Additionally, NCBI's article in 2022 projected the annual incidence of PAD to be nearly 10 million.

An increase in strategic initiatives amongst the key players of iliac stents is anticipated to propel growth. For instance, in January 2024, Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval from the National Medical Products Administration (NMPA) for its peripheral venous stent system. Furthermore, in October 2023, Getinge AB announced the commercial availability of its product, iCast covered stent system to treat iliac arterial occlusive disease in the U.S.

Iliac Stents Market Report Highlights:

  • The iliac stents marketin the healthcare industry was estimated at USD 1.03 Billion in 2023 and is expected to reach USD 1.53 Billion in 2030
  • The iliac stents marketis expected to grow at a compound annual growth rate of 5.8% from 2024 to 2030 to reach USD 1.53 Billion by 2030
  • In 2023, North America held the largest share in the iliac stents market, with a revenue share of 43.7%. The growing geriatric population in the U.S., which is susceptible to PAD is expected to increase the demand for stenting procedures, thereby significantly contributing to the market growth over the forecast period
  • By type, self-expandable stents segment accounted for the largest revenue share of 60.4% in 2023driven by favorable long-term clinical study results for these stents that are expected to instill confidence in healthcare providers
  • By artery lesions, the common iliac artery lesions segment accounted for the largest revenue share of 60.5% in 2023 driven by growing cases of patients suffering from high cholesterol and obesity are expected to boost the demand for iliac stents, as these conditions cause plaque buildup, which narrows or blocks artery lumen
  • By end use, hospital segment accounted for a dominant revenue share of 61.7% in 2023. Hospitals serve as referral centers where patients receive comprehensive care, including diagnostic imaging, medical management, and interventional procedures like iliac stent placement

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Artery lesions
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for Primary Interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Parent market analysis (Model 2)
    • 1.7.4. Approach 2: Parent market analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment outlook
    • 2.2.1. Type outlook
    • 2.2.2. Artery lesions outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Iliac Stents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of peripheral artery disease (PAD)
      • 3.2.1.2. Technological advancements in iliac stents
      • 3.2.1.3. Increasing number of product approvals in developed and developing countries
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of reimbursement policies for venous stenting
      • 3.2.2.2. Product recalls
  • 3.3. Iliac Stents Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Iliac Stents Market: Type Estimates & Trend Analysis

  • 4.1. Iliac Stent Market: Type Dashboard
  • 4.2. Iliac Stent Market: Type Movement Analysis
  • 4.3. Iliac Stents Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Self-Expandable Stents
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Balloon-Expandable Stents
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Iliac Stents Market: Artery Lesions Estimates & Trend Analysis

  • 5.1. Iliac Stent Market: Artery Lesions Dashboard
  • 5.2. Iliac Stent Market: Artery Lesions Movement Analysis
  • 5.3. Iliac Stents Market Size & Forecasts and Trend Analysis, by Artery Lesion, 2018 to 2030 (USD Million)
  • 5.4. Common Iliac Artery Lesions
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Severe Calcified Lesions
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Complete Obstructive Lesions
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Iliac Stents Market: End-Use Estimates & Trend Analysis

  • 6.1. Iliac Stent Market: End-Use Dashboard
  • 6.2. Iliac Stent Market: End-Use Movement Analysis
  • 6.3. Iliac Stents Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Outpatient Facilities
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Iliac Stents Market: Regional Estimates & Trend Analysis by Country, Type, Artery Lesions, & End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Mexico
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Argentina
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa Market Estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. BD
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Abbott
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Boston Scientific Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. W. L. Gore & Associates, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Cook
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Medtronic
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Vascular
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Terumo Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Getinge AB
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Biotronik SE & Co KG
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives